significantly lower than that in the controls (151.9 (32.1) mg/ml, p<001). Division of patients and controls into three age groups showed that the reduction in bone mineral content was most marked in the youngest age group (21- rheumatoid arthritis,'8 who were enrolled into a trial of second line treatment, were studied. Fifty one were female and the mean (SD) age of all patients was 51-7 (9-6) years (range 26-71). The median duration of disease was four years (range . None had received systemic steroid treatment at any time, though 14 had received intra-articular steroids. Seventy six patients had erosive disease and 77 patients were seropositive. Most patients were taking one or more of a variety of nonsteroidal anti-inflammatory drugs; in addition, all were receiving second line drug treatment consisting of one of the following: penicillamine (maximum 500 mg/day) (n=31), hydroxychloroquine (400 mg/day) (n=20), and auranofin (6 mg/day) or intramuscular sodium aurothiomalate (50 mg/month) (n=37). Patients who were housebound or restricted to a wheelchair were excluded from the study as were those with a history of gastrointestinal disease or surgery, liver disease, chronic renal disease, endocrine disease, or known metabolic bone disease. Permission to carry out the study was granted by the local ethical committee. Disability was assessed by the Steinbroker'9 and the London 20 methods. The London score ranged from 0 to 3 (median 1.25).
Steinbroker assessment placed 11 patients in class 1, 62 in class 2, and 15 in class 3. Control data for quantitative computed tomography were obtained from 105 healthy subjects, 57 female, aged years (mean (SD) 45-8 (13.8)).
MEASUREMENT OF SPINAL TRABECULAR BONE MINERAL CONTENT
Spinal trabecular bone mineral content was measured in the anterior part of the first three lumbar vertebrae by quantitative computed tomography (CT) with a Philips 350 x ray CT scanner, using a modification of the method of Cann and Genant.21
Patients were positioned with the lumbar spine over a phantom containing tubes of various salt solutions and water. Scans were made through the middle of each vertebra, using a slice thickness of 6 mm, field of view of 400 mm, and tube voltage of 120 kV, and the CT number within the vertebral body of Li, L2, and L3 was compared with those of the salt solutions. In this way mineral concentrations were calculated in terms of an equivalent concentration of K2HPO4 solution, a salt which has radiographic attenuation properties similar to those of calcium hydroxyapatite. The results were corrected for the contribution of non-mineral components to the attenuation coefficient, using calculated values of estimated soft tissue corrections based on published tissue composition data.22 The lateral digital pictures of the lower dorsal vertebrae (Ti 1 and T12) and all the lumbar vertebrae in all the patients and Spinal bone mass in rheumatoid arthritis 661 controls were examined by a consultant radiologist (CE) for the presence of compression fractures.
STATISTICAL ANALYSIS
Correlations between continuous variables were examined by linear regression analysis, and the significance of the correlation coefficient was determined by a Student's two tailed t test. Relations between continuous and non-continuous data were examined by two tailed Student's t tests and one way analysis of variance. Differences between patients and controls were tested using an unpaired two tailed t test or, in the case of the 21-40 year old men, by the Wilcoxon rank sum test. Results
When all the patients were considered as one group the mean (SD) spinal trabecular bone mineral content, 135-8 (32-8) mg/ml K2HPO4, was significantly lower than that in the controls (151.9 (32-1) mg/ml, p<0-01). Six patients, three women aged 50, 61, and 64 years and three men aged 39, 48, and 58 years, had abnormally low values, defined as a bone mineral content >2 SD below the mean value of age and sex matched controls. Division of female and male patients and controls into three age groups (Figs 1 and 2) showed that the reduction in bone (0) 77-6 76-2 (7-2)
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*p<O-01.
tValues are mean (SD).
Wv subgroup of these patients the iliac crest trabecular bone volume, assessed histomorphometrically, was reduced in younger patients with rheumatoid arthritis compared with age and sex matched controls, whereas bone volume in older patients was normal. 23 The results of these two studies therefore suggest that rheumatoid arthritis may be associated with premature bone loss, though the total amount of bone lost during the aging process appears to be similar to that of the normal population; longitudinal studies would be necessary to confirm this. Previous studies of spinal bone mineral content in rheumatoid arthritis have produced conflicting results. Thus although Sambrook et al reported reduced bone mineral content in the lumbar spine, measured by dual photon absorptiometry, in a total of 84 steroid treated and non-steroid treated patients,24 Verstraeten and Dequeker using the same method were unable to demonstrate any reduction in 104 postmenopausal patients7; indeed, non-steroid treated patients were found to have a higher spinal bone mineral content than the controls. In the only longitudinal study of spinal bone density in patients with rheumatoid arthritis Sambrook et al were unable to show any increase in the rate of bone loss from the spine in a small group of patients with recent onset, non-steroid treated rheumatoid arthritis.25 Only a small number of patients were studied, however, and the follow up period was short.
Total body calcium, which is predominantly a measurement of peripheral cortical bone mass, has also been evaluated in a number of studies. Low total body calcium has been reported in patients with rheumatoid arthritis receiving steroids,9 26 though this finding has not been invariable27; both low9' 6 and normal27-29 total body calcium have also been reported in non-steroid treated patients. More localised measurements of radial bone mass, which includes both cortical and trabecular bone, have been made using single photon absorptiometry; most of these studies have reported reduced midshaft5 II and distal7 26 radial bone mineral content in steroid treated patients7 26 and in some cases, in non-steroid treated patients also.7 26 30) 31 In addition, an increased rate of trabecular bone loss from the distal radius was reported by Sambrook et al. 25 In the present study only patients not receiving steroids were included so that steroid induced effects on bone mass could be excluded. In The clinical significance of reduced bone mass associated with rheumatoid arthritis depends on the degree and site of reduction and the changes in bone structure accompanying bone loss. In the final analysis, as fracture is the most important clinical event in osteoporosis, clinical significance is best assessed in terms of the impact, if any, of bone loss on fracture rate. Two studies have indicated that there is an increased risk of osteoporotic fracture associated with rheumatoid arthritis; in one of these this was found only in steroid treated patients,7 whereas in the other some increase in fracture risk was found in both steroid and nonsteroid treated patients, though the risk was higher in the steroid users; disability and long duration of disease were also associated with increased fracture rate." In the present study no significant increase in vertebral fracture rate was found in the patients compared with controls; further studies are required to establish definitely whether or not the incidence of osteoporotic fracture is increased in non-steroid treated patients with rheumatoid arthritis. 
